Live News Categoriesequity

Hanmi Pharm. Co., Ltd. (128940.KS) News

Follow Hanmi Pharm. Co., Ltd. (128940.KS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 128940.KS Asset equity Sector Markets 90 days 1 Last 534,000 Updated Oct 07, 2026, 10:03 AM UTC Open live news feed

M Hanmi Pharma gets South Korea approval for Efpeo auto-injector obesity drug South Korea's MFDS granted marketing authorization for Hanmi Pharmaceutical’s Efpeo Auto-Injector (efpeglenatide), an obesity drug for chronic weight management. Approval covers five strengths; indicated for adults with EQUITY | Oct 07, 2026, 10:03 AM UTC